Alimo PeptideTirzepatide
Ordered Tirzepatide from Alimo Peptide? Mail in a sample (US only) and let us test it for free.
Test my supplyAlimo Peptide's tirzepatide record is dragged down by fill volatility: 2025 tests were +79% and +50% overfilled despite passing identity and purity. A later clean result helps, but sparse tests and batch gaps leave uncertainty.
Alimo’s US listing collides with a Shanghai-branded sales identity, while the canonical storefront is gone and ordering now routes through a public document, messaging apps, and crypto. The report maps forum activity, warehouse claims, COA links, and complaint-handling signals.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Alimo Peptide rows.
Cancel anytime
About Alimo Peptide test results from Finnrick
Alimo Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 8 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Alimo Peptide peptides in this dataset are Retatrutide (3 tests) and Tirzepatide (5 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 8 recent tests.
Ordered Tirzepatide from Alimo Peptide? Mail in a sample (US only) and let us test it for free.
Test my supply